Date: May 1, 2019
Time: All-day
Location: Paris, France
2019 in Palais des Congrès – Paris, France
Recent Posts
- Early Feasibility Study (EFS) for NCSI’s GATE™ System is approved by FDA
- iVascular SLU, Barcelona Invests in NaviGate Cardiac Structures, Inc.
- Quebec University in Laval, Canada. This is the first tricuspid valve replacement in Canada.
- NaviGate Cardiac Structures, Inc., presents data of studies on the Gate™ valved stent for correction of Functional Tricuspid Regurgitation at Paris PCR2016.